33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Uterine leiomyosarcoma with a novel RAB2A-PLAG1 gene fusion
    Meeting Abstract

    Hosseini, H.; Vele, O.; Unger, P.; O'Leary, X.; DiNapoli, S. E.; Mullaney, K.; Zaidinski, M.; Sukhadia, P.; Benhamida, J. K.; Soslow, R. A.; more...
    American Journal of Clinical Pathology (2022)

    Fulltext@MSK | Save
  • Subcutaneous epcoritamab combined with R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma: Phase 1/2 update
    Meeting Abstract

    Falchi, L.; Offner, F.; Belada, D.; Brody, J.; Linton, K. M.; Karimi, Y.; Cordoba, R.; Snauwaert, S.; Abbas, A.; Wang, L.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Primary analysis of phase 2 results for cemiplimab in patients with mBCC who progressed on or were intolerant to hedgehog inhibitors
    Meeting Abstract

    Lewis, K. D.; Peris, K.; Sekulic, A.; Stratigos, A. J.; Dunn, L.; Eroglu, Z.; Chang, A. L. S.; Migden, M. R.; Yoo, S. K.; Mohan, K.; more...
    Journal of Oncology Navigation & Survivorship (2022)

    Fulltext@MSK | Save
  • Intracranial activity of tepotinib in patients with MET Exon 14 (METex14) skipping non-small-cell lung cancer (NSCLC) enrolled in VISION
    Meeting Abstract

    Hill, R.; Leighl, N.; Bestvina, C.; Patel, J.; Le, X.; Veillon, R.; Anderson, I.; Demedts, I.; Garassino, M. C.; Mazières, J.; more...
    Journal of Oncology Navigation & Survivorship (2022)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Prophylactic radiation therapy vs. standard-of-care for patients with high-risk, asymptomatic bone metastases: A multicenter, randomized phase II trial
    Meeting Abstract

    Gillespie, E. F.; Mathis, N. J.; Marine, C.; Zhang, Z.; Barker, C. A.; Guttmann, D. M.; Kotecha, R.; McIntosh, A. F.; Vaynrub, M.; Bartelstein, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC) (NCT01730937)
    Meeting Abstract

    Dawson, L. A.; Winter, K.; Knox, J.; Zhu, A. X.; Krishnan, S.; Guha, C.; Kachnic, L. A.; Gillin, M. T.; Hong, T. S.; Craig, T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): A multicenter, randomized phase II trial
    Meeting Abstract

    Tang, C.; Sherry, A. D.; Haymaker, C.; Bathala, T.; Liu, S.; Fellman, B.; Aparicio, A.; Zurita-Saavedra, A.; Chun, S.; Reddy, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Matching adjusted indirect comparison of PFS & OS comparing ribociclib + letrozole vs palbociclib + letrozole as first-line treatment of HR+/HER2− ABC: Analysis based on updated PFS & final OS results of MONALEESA-2 & PALOMA-2
    Meeting Abstract

    Jhaveri, K.; O'Shaughnessy, J.; Fasching, P.; Cardoso, F.; Tolaney, S.; Hamilton, E.; Sharma, V. K.; Biswas, C.; Haftchenary, S.; Pathak, P.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • DNA methylation analysis of endometrial carcinomas identifies molecularly and clinically distinct subgroups
    Meeting Abstract

    Li, J.; Kommoss, F.; Lum, A.; Chiu, D.; Yuan, V.; Leung, S.; Huntsman, D. G.; McAlpine, J. N.; von Deimling, A.; Tessier-Cloutier, B.
    Virchows Archiv (2022)

    Fulltext@MSK | Save